» Articles » PMID: 36045424

Hypertoxic Self-assembled Peptide with Dual Functions of Glutathione Depletion and Biosynthesis Inhibition for Selective Tumor Ferroptosis and Pyroptosis

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2022 Aug 31
PMID 36045424
Authors
Affiliations
Soon will be listed here.
Abstract

Abundant glutathione (GSH) is a biological characteristic of lots of tumor cells. A growing number of studies are utilizing GSH depletion as an effective adjuvant therapy for tumor. However, due to the compensatory effect of intracellular GSH biosynthesis, GSH is hard to be completely exhausted and the strategy of GSH depletion remains challenging. Herein, we report an L-buthionine-sulfoximine (BSO)-based hypertoxic self-assembled peptide derivative (NSBSO) with dual functions of GSH depletion and biosynthesis inhibition for selective tumor ferroptosis and pyroptosis. The NSBSO consists of a hydrophobic self-assembled peptide motif and a hydrophilic peptide derivative containing BSO that inhibits the synthesis of GSH. NSBSO was cleaved by GSH and thus experienced a morphological transformation from nanoparticles to nanofibers. NSBSO showed GSH-dependent cytotoxicity and depletion of intracellular GSH. In 4T1 cells with medium GSH level, it depleted intracellular GSH and inactivated GSH peroxidase 4 (GPX4) and thus induced efficient ferroptosis. While in B16 cells with high GSH level, it exhausted GSH and triggered indirect increase of intracellular ROS and activation of Caspase 3 and gasdermin E, resulting in severe pyroptosis. These findings demonstrate that GSH depletion- and biosynthesis inhibition-induced ferroptosis and pyroptosis strategy would provide insights in designing GSH-exhausted medicines.

Citing Articles

Immune imbalance in Lupus Nephritis: The intersection of T-Cell and ferroptosis.

Fan Y, Ma K, Lin Y, Ren J, Peng H, Yuan L Front Immunol. 2024; 15:1520570.

PMID: 39726588 PMC: 11669548. DOI: 10.3389/fimmu.2024.1520570.


A minimalist multifunctional nano-prodrug for drug resistance reverse and integration with PD-L1 mAb for enhanced immunotherapy of hepatocellular carcinoma.

Zou T, Huang Y, Zhou Z, He S, Liu J, Chen Y J Nanobiotechnology. 2024; 22(1):750.

PMID: 39627819 PMC: 11613529. DOI: 10.1186/s12951-024-03027-w.


Intelligent Pyroptosis Inducer for Precise and Augmented Tumor Therapy Through Specific Activation Pyroptosis in Tumor.

Huo L, Zhu S, Li M, Tan M, Fan M, Zhao J Adv Sci (Weinh). 2024; 12(3):e2407713.

PMID: 39604790 PMC: 11744558. DOI: 10.1002/advs.202407713.


Augment of Ferroptosis with Photothermal Enhanced Fenton Reaction and Glutathione Inhibition for Tumor Synergistic Nano-Catalytic Therapy.

Song Q, Zhang Y, Hu H, Yang X, Xing X, Wu J Int J Nanomedicine. 2024; 19:11923-11940.

PMID: 39574433 PMC: 11579141. DOI: 10.2147/IJN.S480586.


Research Progress on Ferroptosis and Nanotechnology-Based Treatment in Triple-Negative Breast Cancer.

Zhang J, Zhang S, Liu M, Yang Z, Huang R Breast Cancer (Dove Med Press). 2024; 16:347-358.

PMID: 39050766 PMC: 11268712. DOI: 10.2147/BCTT.S475199.


References
1.
Liang C, Zhang X, Yang M, Dong X . Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019; 31(51):e1904197. DOI: 10.1002/adma.201904197. View

2.
Qi G, Gao Y, Wang L, Wang H . Self-Assembled Peptide-Based Nanomaterials for Biomedical Imaging and Therapy. Adv Mater. 2018; 30(22):e1703444. DOI: 10.1002/adma.201703444. View

3.
Deng Y, Jia F, Chen S, Shen Z, Jin Q, Fu G . Nitric oxide as an all-rounder for enhanced photodynamic therapy: Hypoxia relief, glutathione depletion and reactive nitrogen species generation. Biomaterials. 2018; 187:55-65. DOI: 10.1016/j.biomaterials.2018.09.043. View

4.
Skouta R, Dixon S, Wang J, Dunn D, Orman M, Shimada K . Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014; 136(12):4551-6. PMC: 3985476. DOI: 10.1021/ja411006a. View

5.
De Vasconcelos N, Van Opdenbosch N, Van Gorp H, Parthoens E, Lamkanfi M . Single-cell analysis of pyroptosis dynamics reveals conserved GSDMD-mediated subcellular events that precede plasma membrane rupture. Cell Death Differ. 2018; 26(1):146-161. PMC: 6294780. DOI: 10.1038/s41418-018-0106-7. View